CFDE Data Portal | Search TUBAP8

	Label	Description
	TUBAP8 Gene (Entity type)	ENSG00000238145 - tubulin alpha pseudogene 8
	GSE151090 verteporfin 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 1 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE133661 C19orf12 knockdown A-549 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Thyroid 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx AdiposeTissue 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE74383 ROR2 overexpression MCF-7 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE163282 aspirin 0 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS

TUBAP8

ENSG00000238145 - tubulin alpha pseudogene 8

GSE151090 verteporfin 2 v 1 human dn

A Gene Set from LINCS

GSE119369 H10 inhibition 1 v 6 human dn

A Gene Set from LINCS

GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human up

A Gene Set from LINCS

GSE133661 C19orf12 knockdown A-549 0 v 1 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 10 human up

A Gene Set from LINCS

GTEx Thyroid 20-29 vs 30-39 Up

A Gene Set from GTEx

GTEx AdiposeTissue 20-29 vs 70-79 Down

A Gene Set from GTEx

GSE74383 ROR2 overexpression MCF-7 2 v 3 human up

A Gene Set from LINCS

GSE163282 aspirin 0 v 8 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.